000006229 000__ 01163cam\a22003255i\4500
000006229 001__ 6229
000006229 003__ SzGeWIPO
000006229 005__ 20240708160650.0
000006229 008__ 940205s1993\\\\nyu\\\\\r\\\\u000\0\eng\d
000006229 035__ $$a(wipo)(CD )$34990
000006229 035__ $$a(OCoLC)1158931673
000006229 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000006229 084__ $$a64$$qUS
000006229 1001_ $$aBass, Scott I.,$$eauthor.
000006229 24510 $$aPrescription drug advertising under the Lanham Act /$$cScott I. Bass.
000006229 264_1 $$aNew York, New York :$$bInternational Trademark Association,$$c1993.
000006229 300__ $$a1 volume ([32] pages) ;$$c[28] cm.
000006229 336__ $$atext$$btxt$$2rdacontent
000006229 337__ $$aunmediated$$bn$$2rdamedia
000006229 338__ $$avolume$$bnc$$2rdacarrier
000006229 4901_ $$aThe Trademark Reporter ;$$v1993 Vol 83 No 4 pages 521-553
000006229 650_0 $$aTrademarks.
000006229 650_4 $$aMARKS : PROTECTED SUBJECT MATTERS AND CATEGORIES OF MARKS
000006229 650_4 $$aLANHAM ACT : DRUG ADVERTISING
000006229 7001_ $$aHallerman, Stacey.
000006229 830_0 $$aTrademark Reporter ;$$v1993 Vol 83 No 4 pages 521-553.
000006229 903__ $$v1$$aTHE TRADEMARK REPORTER
000006229 904__ $$aJournal article
000006229 942__ $$cART$$2ddc
000006229 952__ $$w2006-11-03$$p1994-34990$$r0.00$$u6541$$bMAIN$$10$$kUS 64$$v1994-02-05$$zLibrary$$70
000006229 980__ $$aBIB
000006229 999__ $$c6482$$d6482